Evidence map›Paper›PMID 42738327›Full record

ArticleCancers2026

Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study.

Ryotaro Ohkuma, Tomoyuki Ishiguro, Hirotsugu Ariizumi, Masahiro Shimokawa, Go Ikeda, Takahiro Yoshizawa, Yuya Hirasawa, Risako Suzuki, Toshiaki Tsurui, Emiko Mura and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Ryotaro OhkumaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0003-4121-2491
Tomoyuki IshiguroDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Hirotsugu AriizumiDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Masahiro ShimokawaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0002-8645-4112
Go IkedaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0009-0006-7333-7095
Takahiro YoshizawaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Yuya HirasawaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Risako SuzukiDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Toshiaki TsuruiDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0002-6167-8953
Emiko MuraDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Rika SasakiDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Shuichi KomoriDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Kosuke ToyofukuDivision of Radiation Oncology, Department of Radiology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Masako KatoDivision of Radiation Oncology, Department of Radiology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0009-0008-8272-5625
Kanae ShimadaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Shingo MiyamotoDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Kouzou MurakamiShowa Medical University Comprehensive Cancer Information Center, Showa Medical University, Tokyo 142-8555, Japan.
Yoshihiro NakagamiDepartment of Urology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0002-3245-1370
Kazuhiko OshinomiDepartment of Urology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Yutaro KubotaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Hiroo IshidaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Takeshi AokiDivision of Gastroenterological & General Surgery, Department of Surgery, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Masahiko MurakamiDivision of Gastroenterological & General Surgery, Department of Surgery, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Kiyoshi YoshimuraDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
Satoshi WadaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0001-6528-5914
Katsuhito TakahashiDepartment of Sarcoma Oncology, Kameda Medical Center, Chiba 296-8602, Japan.ORCID 0000-0003-2034-8568
Takuya TsunodaDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0002-6416-8211
Atsushi HoriikeDepartment of Oncology, Graduate School of Medicine, Showa Medical University, Tokyo 142-8555, Japan.ORCID 0000-0001-6941-7494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combined modality therapyneoplasm metastasisprogression-free survivalretrospective studiessarcomasoft tissue neoplasms

Identifiers

PMID42738327
PMCPMC13565411

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.